Skip to main content
MedinCell S.A. logo

MedinCell S.A. — Investor Relations & Filings

Ticker · MEDCL ISIN · FR0004065605 LEI · 969500R79U6PXCL2FF46 PA Manufacturing
Filings indexed 4 across all filing types
Latest filing 2025-07-29 Annual Report (ESEF)
Country FR France
Listing PA MEDCL

About MedinCell S.A.

https://www.medincell.com/en/

MedinCell S.A. is a pharmaceutical company at the commercial stage that specializes in the development of long-acting injectable (LAI) therapies. The company's core is its proprietary BEPO® technology platform, which enables the controlled and sustained release of active pharmaceutical ingredients over periods ranging from days to months after a single injection. This technology forms a fully biodegradable depot in situ, designed to improve treatment efficiency, enhance patient compliance, and increase the global accessibility of medicines. MedinCell develops a portfolio of LAI products across various therapeutic areas, including psychiatry, advancing its pipeline through both internal research and strategic partnerships with other pharmaceutical organizations.

Recent filings

Filing Released Lang Actions
DEU MEDINCELL 2024-2025
Annual Report (ESEF) Classification · 100% confidence FY 2025
2025-07-29 French
DEU Medincell - exercice clos 31 mars 2024
Annual Report (ESEF) Classification · 100% confidence FY 2024
2024-07-26 French
DEU Medincell - exercice clos 31 mars 2024
Annual Report (ESEF) Classification · 100% confidence FY 2024
2024-07-26 French
Document d'Enregistrement Universel DEU MedinCell 31 03 2022
Annual Report (ESEF) Classification · 100% confidence FY 2022
2022-07-28 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.